Presentation TCT 2025 TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis Presenter: Mehmet Cilingiroglu October 28, 2025
Presentation TCT 2025 TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis Presenter: Amer Hussein Muhyieddeen October 27, 2025
Presentation TCT 2025 TCT 794: Impact of Statin Therapy on Long-term Clinical Outcomes in Coronary Artery Spasm Patients without Dyslipidemia and Coronary Artery Stenosis Presenter: Melly Susanti October 26, 2025
Presentation TCT 2025 TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients Presenter: Woohyeun Kim October 26, 2025
Presentation TCT 2025 TCT 1197: High-Dose Statin Preloading in Acute Coronary Syndrome Patients Prior to PCI: Impact on Long-Term Clinical Outcomes Presenter: Mehmet Cilingiroglu October 26, 2025
Presentation TCT 2024 TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis Presenter: Montaser Elkholy October 30, 2024
Presentation TCT 2024 What Happens Next? Beyond Statins for Optimizing LDL-C Management After Coronary and Peripheral Intervention Presenter: David Kwon October 29, 2024
Presentation TCT 2024 TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis Presenter: Hyun Jin Ahn October 28, 2024
Presentation ACC 2024 Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration Presenter: Steven E. Nissen April 08, 2024
Presentation Controversies and Advances 2023 Update on Lipid Management: Non-Statin Lipid Modifying Therapies Presenter: Alan S. Brown November 30, 2023
Presentation AHA 2023 Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program Presenter: Alexander C. Fanaroff November 13, 2023
Presentation TCT 2023 TCT 174: The Impact of Pre-Hospital Statin Therapy on Cardiovascular Events in STEMI Patients without a History of Revascularization: Insights from the TWINCRE Registry Presenter: KEI INUTSUKA October 26, 2023
Presentation TCT 2023 TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy Presenter: Jung-Hee Lee October 25, 2023
Presentation TCT 2023 TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study Presenter: Ji-Yong Jang October 25, 2023
Presentation TCT 2023 TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data… Presenter: Young-Hoon Seo October 25, 2023
Presentation TCT 2023 TCT 645: Changes in Plaque Lipid Content After 1 year Intensive Versus Standard Statin Therapy : CITRUS study (Serial near-infrared spectroscopy assessment of change in coronary atherosclerotic plaque) Presenter: Sanghoon Shin October 25, 2023
Presentation ACC 2023 A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin) Presenter: Salim Virani March 05, 2023
Presentation TCT 2022 TCT 577: Lipoprotein (a) and Intracoronary Imaging After Intensive Statin Treatment Presenter: Shingo Minatoguchi September 19, 2022
Presentation Controversies and Advances 2021 EPA Fish Oil: Who Should Receive It? Presenter: Peter P. Toth December 03, 2021
Presentation AHA 2019 Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study Presenter: Matthew Budoff November 18, 2019